Photo - Cytosimilars
54572

Cytosimilars

Germany
Market: Medicine, Pharmacology
Stage of the project: Prototype or product is ready

Date of last change: 02.12.2021
Go to the owner's profile
1
equalizer from 2000
help
Calculated and estimated occupancy of the project (more about ratings)
My rating
1
2
3
4
5
6
7
8
9
10
Average rating:
 

Idea

We combine biotechnology and personalized alternative medicine.
We are the blueprint for a new pharma culture: open medicine, clean medicine, greenlab, based on an economy for the common good.

Current Status

Team complete
Option for a fully equipped lab
Proof of concept done
Excellent scientific and professional network
Working on two patents with WBH Wachenhausen Patentanwälte
MVP available in 18 month

Problem or Opportunity

Approximately 2 billion people do not have access to effective medicine. This is particularly true for severe pathologies such as cancer. There is an urgent need to address issues such as antibiotic resistance, healthy aging, cost explosion in health care, unmet medical needs and lack of sustainability. Patients in industrialised countries seek integrative medicine that combines the best of conventional and alternative methods.

Solution (product or service)

Establish personalised medicine in complementary medicine (companion diagnostics).
Optimise biotechnological procedures using alternative medicine.
Develop own medicines for different acute and chronic diseases.
Introduce systematic state-of-the-art cell-based research in complementary medicine.

Business model

Licensing of biotechnological processes
Companion Diagnostics for personalised information medicine
Development of new drugs for oncology, allergies and inflammatory diseases
5,00
1
2
3
4
5
1 voice
Sign in/Sign up
arrow_back
EN
more_horiz
close
visibility447
star0
Add to favorites
Delete from favorites
share
close
thumb_up0
Like
Unlike
Idea
Current Status
Market
Problem or Opportunity
Solution (product or service)
Competitors
Advantages or differentiators
Finance
Invested in previous rounds, $
Business model
Money will be spent on
Offer for investor
Team or Management
Mentors & Advisors
Lead investor
Risks
Incubation/Acceleration programs accomplishment
Won the competition and other awards
Invention/Patent
Product Video
Presentation